fotos subir_TORRE 36 - RAMON GONZALEZ MANZANO-Photoroomfotos subir_TORRE 36 - RAMON GONZALEZ MANZANO-Photoroom

Ramón González Manzano

MEDICAL ONCOLOGY SPECIALIST
Medical oncology
See more specialists on Alicantealicante

en/medical-staff/oncologist

Dr. Ramón González Manzano is a leading medical oncologist, currently practicing as a specialist in medical oncology at the Hospital Quirón salud . His academic background includes a PhD in Medicine from the Facultad de Medicina de la Universidad de Navarra, obtained in 1994. Throughout his career, he has made significant contributions to the field of oncology, notably his publication in the journal Oncogene entitled "CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential," published in 2002. This work reflects his commitment to research and the advancement of cancer treatment. His professional experience also includes roles at renowned institutions such as the National Cancer Institute , where he worked as a postdoctoral researcher. Dr. González Manzano continues his work in the field of oncology, contributing his experience and knowledge to the development of new therapeutic strategies.

Key information

  • Latest Publication:
    A novel EGFR nonsense mutation in a non-small-cell lung cancer (NSCLC) patient who did not derive any clinical benefit with combination chemotherapy and erlotinib

Professional Details

Hospital Quirónsalud Torrevieja
SPECIALIST PHYSICIAN MEDICAL ONCOLOGY
October 2006 - Present
Hospital de Sant Jaume
Medical Oncologist
August 2003 - January 2004
Fundación para la Investigación Médica Aplicada (FIMA), Universidad de Navarra
Research Collaborator
October 2001 - May 2003
National Cancer Institute
Postdoctoral Researcher
October 1997 - September 2001
MRC Centre de Cambridge
Researcher
January 1995 - December 1995
Hospital Universitario Marques de Valdecilla
Interim Attending Physician
January 1993 - September 1993
Study
Bachelor of Medicine
Universidad de Navarra
1987
Doctorate
Facultad de Medicina, Universidad de Navarra
1994
Specialized Healthcare Training
Medical Oncology
Project for the application of next-generation sequencing technologies in oncology
Application of expression microarray techniques in predicting the efficacy of antineoplastic agents in cancer patients
2010 - Present
A novel EGFR nonsense mutation in a non-small-cell lung cancer (NSCLC) patient who did not derive any clinical benefit with combination chemotherapy and erlotinib
Article
CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential
Article
ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours
Article
Identification of cJun-responsive genes in Rat-1a cells using multiple techniques: increased expression of stathmin is necessary for cJun-mediated anchorage-independent growth
Article
Mitogen-Activated Protein Kinase Phosphatase-1 (CL100/MKP-1) is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients
Article
RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
Journal Article
Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies.
Journal Article, Review
Make an appointment with this professional